Galectin Therapeutics Inc.

Galectin Therapeutics Inc. financial statements

Galectin Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 30.84M10-K
Cash and equivalentsUSD 17.72M10-Q
Total debtUSD 133.76MEODHD

Galectin Therapeutics Inc. financials on 6ix · Galectin Therapeutics Inc. on 6ix